CMV Intensive Care Units

Completed

• Conditions: CMV Infection

• Registration Number: NCT02324244
• Lead Sponsor: Emilio Bouza

Brief Summary

Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a broad cohort of consecutive immunocompetent adults admitted to a major heart surgery intensive care unit (MHS-ICU) with the goal of determining the epidemiology, risk factors, and clinical significance of CMV infection.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Primary Completion: 2013-05
• Study Completion: 2013-05
• Study First Submitted: 2014-11-26
• Status Verified: 2014-12
• Study First Submitted QC: 2014-12-23
• Last Update Submitted: 2014-12-23
• Study First Posted: 2014-12-24
• Last Update Posted: 2014-12-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Agreeing to participate in the study
• Age of at least 18 years
• Admission to the MHS-ICU for at least 72 hours

Exclusion Criteria

• Inability to give informed consent
• Age younger than 18 years
• AIDS
• Pregnancy
• Organ or bone marrow transplant, receipt of immunosuppressive therapy including corticosteroids within 30 days, and cancer or hematologic malignancy treated with radiotherapy or chemotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence number of participants with a positive CMV positive result	month 8

Secondary Outcome Measures

Name	Time	Method
risk factors for CMV reactivation	month 8
mortality by day 30	month 8	composite endpoint. hospitalization or death by day 30
prolonged hospitalization . More than 30 days	month 8

Trial Locations

Locations (1)

Servicio de Microbiologia y Enfermedades Infecciosas; 🇪🇸 Madrid, Spain